Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 19, Issue 8, 2008, Pages 1483-1490

  Litjens, Nicolle Helena Renier ^a   Huisman, Martin ^b   Van Den Dorpel, Marinus ^b   Betjes, Michiel Gerardus Henricus ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT HEPATITIS B VACCINE; CYTOKINE;

ADULT; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; KIDNEY FAILURE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; VACCINATION; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; DRUG EFFECT; IMMUNOLOGY; KINETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; FEMALE; HEPATITIS B SURFACE ANTIGENS; HUMANS; KIDNEY FAILURE, CHRONIC; KINETICS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; VACCINATION;

EID: 49649087781     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007090971     Document Type: Article

References (33)

1. Kurz P, Kohler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde KH: Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect. Kidney Int 29: 1209-1214, 1986
2. Quadracci LJ, Ringden O, Krzymanski M: The effect of uremia and transplantation on lymphocyte subpopulations. Kidney Int 10: 179-184, 1976
3. Raska K Jr, Raskova J, Shea SM, Frankel RM, Wood RH, Lifter J, Ghobrial I, Eisinger RP, Homer L: T cell subsets and cellular immunity in end-stage renal disease. Am J Med 75: 734-740, 1983
4. Krishnamurthy G, Kher V, Naik S: Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells. Scand J Urol Nephrol 36: 377-382, 2002
5. Libetta C, Rampino T, Dal Canton A: Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 38: 286-295, 2001
6. Sester U, Sester M, Hauk M, Kaul H, Kohler H, Girndt M: T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 15: 1217-1223, 2000
7. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712, 1999
8. Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763, 2004
9. Sallusto F, Langenkamp A, Geginat J, Lanzavecchia A: Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol 251: 167-171, 2000
10. Seder RA, Ahmed R: Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4: 835-842, 2003
11. Litjens NH, van Druningen CJ, Betjes MG: Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 118: 83-91, 2006
12. Yoon JW, Gollapudi S, Pahl MV, Vaziri ND: Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 70: 371-376, 2006
13. De Rosa SC, Lu FX, Yu J, Perfetto SP, Falloon J, Moser S, Evans TG, Koup R, Miller CJ, Roederer M: Vaccination in humans generates broad T cell cytokine responses. J Immunol 173: 5372-5380, 2004
14. Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II, Haemodialysis patients. Lancet 1: 797-800, 1981
15. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W: Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 311: 496-501, 1984
16. McKerrow KJ, Hawthorn RJ, Thompson W: An investigation of circulating and in situ lymphocyte subsets and Langerhans cells in the skin and cervix of patients with chronic renal failure. Br J Dermatol 120: 745-755, 1989
17. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kiefer T, Kuhlmann U: Epidermal Langerhans cells in uremic patients on hemodialysis or continuous ambulatory peritoneal dialysis. Nephron 65: 278-283, 1993
18. Hesselink DA, Betjes MG, Verkade MA, Athanassopoulos P, Baan CC, Weimar W: The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol Dial Transplant 20: 1868-1873, 2005
19. Nakanishi K, Cohen DI, Blackman M, Nielsen E, Ohara J, Hamaoka T, Koshland ME, Paul WE: Ig RNA expression in normal B cells stimulated with anti-IgM antibody and T cell-derived growth and differentiation factors. J Exp Med 160: 1736-1751, 1984
20. Rinkenberger JL, Wallin JJ, Johnson KW, Koshland ME: An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 5: 377-386, 1996
21. Turner CA Jr, Mack DH, Davis MM: Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin- secreting cells. Cell 77: 297-306, 1994
22. Kallies A, Nutt SL: Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 19: 156-162, 2007
23. Amu S, Tarkowski A, Dorner T, Bokarewa M, Brisslert M: The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol 66: 77-86, 2007
24. Bergamin F, Vincent IE, Summerfield A, McCullough KC: Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol 37: 3122-3130, 2007
25. Meuer SC, Dumann H, Meyer zum Buschenfelde KH, Kohler H: Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1: 15-18, 1989
26. Ndejembi MP, Teijaro JR, Patke DS, Bingaman AW, Chandok MR, Azimzadeh A, Nadler SG, Farber DL: Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J Immunol 177: 7698-7706, 2006
27. Verkade MA, van Druningen CJ, Vaessen LM, Hesselink DA, Weimar W, Betjes MG: Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol Dial Transplant 22: 128-138, 2007
28. Girndt M, Sester M, Sester U, Kaul H, Kohler H: Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78: 206-211, 2001
29. van Riemsdijk IC, Baan CC, Loonen EH, Knoop CJ, Navarro Betonico G, Niesters HG, Zietse R, Weimar W: T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis. Kidney Int 59: 883-892, 2001
30. Girndt M, Pietsch M, Kohler H: Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 26: 454-460, 1995
31. DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, Kiaii M, Taylor PA, Levin A: Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am J Kidney Dis 42: 1184-1192, 2003
32. Propst T, Propst A, Lhotta K, Vogel W, Konig P: Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 32: 1041-1045, 1998
33. Litjens NH, Huisman M, Baan CC, van Druningen CJ, Betjes MG: Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: Limited usefulness of dendritic cells as signal enhancers. J Immunol Methods 330: 1-11, 2008